Altered prostaglandin E1 dosage during extracorporeal membrane oxygenation in a newborn with ductal-dependent congenital heart disease

Pediatric Cardiology

Volumn 27, Issue 3, 2006, Pages 360-363

  Stone, D M ^a   Frattarelli, D A C ^a   Karthikeyan, S ^a   Johnson, Y R ^a   Chintala, K ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Ductus arteriosus; Extracorporeal membrane oxygenation; Pharmacokinetics; Prostaglandin E1

Indexed keywords

DOPAMINE; NITRIC OXIDE; PROSTAGLANDIN E1; VASODILATOR AGENT;

ARTICLE; ARTIFICIAL VENTILATION; BLALOCK TAUSSIG ANASTOMOSIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONGENITAL HEART DISEASE; DRUG ERUPTION; ERYTHEMA; EXTRACORPOREAL OXYGENATION; FEMALE; HOT FLUSH; HUMAN; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PATENT DUCTUS ARTERIOSUS; PULMONARY HYPERTENSION; TRANSLUMINAL VALVULOPLASTY; TREATMENT OUTCOME; CONGENITAL HEART MALFORMATION; ECHOGRAPHY; MECONIUM ASPIRATION; METABOLISM; PULMONARY VALVE STENOSIS;

ALPROSTADIL; DUCTUS ARTERIOSUS, PATENT; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; MECONIUM ASPIRATION SYNDROME; PULMONARY VALVE STENOSIS; VASODILATOR AGENTS;

EID: 33744787075     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-005-1189-8     Document Type: Article

References (14)

1. 1 in patients with pulmonary hypertension. Masui 44:536-541
2. Bartlett RH, Andrews AF, Toomasian JM, Haiduc NJ, Gazzaniga AB (1982) Extracorporeal membrane oxygenation for newborn respiratory failure: forty-five cases. Surgery 92:425-433
3. Buck ML (2003) Pharmacokinetic changes during extracorporeal membrane oxygenation:implications for drug therapy of neonates. Clin Pharmacokinet 42:403-417
4. 1 during continuous intravenous infusion in patients with adult respiratory distress syndrome. Am Rev Rev Respir Dis 137:5-12
5. Dagan O, Klein J, Gruenwald C, et al. (1993) Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs. Ther Drug Monit 15:263-266
6. Dalton HJ, Siewers RD, Fuhrman BP, et al. (1993) Extracorporeal membrane oxygenation for cardiac rescue in children with severe myocardial dysfunction. Crit Care Med 21:1020-1028
7. Gotteiner NL, Harper WR, Gidding SS, et al. (1997) Echocardiographic prediction of neonatal ECMO outcome. Pediatr Cardiol 18:270-275
8. Ishino K, Weng Y, Alexi-Meskishvili V, et al. (1996) Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in children. Artif Organs 20:728-732
9. Kanter KR, Pennington G, Weber TR, et al. (1987) Extracorporeal membrane oxygenation for postoperative cardiac support in children. J Thorac Cardiovasc Surg 93:27-35
10. Noerr B (1996) ECMO and pharmacotherapy. Neonatal Network 15:23-31
11. Siberry GK, Iannone R (2000) The Harriet Lane Handbook. A Manual for Pediatric House Officers Mosby, St. Louis
12. Stolar CJ, Snedecor SM, Bartlett RH (1991) Extracorporeal membrane oxygenation and neonatal respiratory failure: experience from the extracorporeal life support organization. J Pediatr Surg 26:563-571
13. Tanke R, Daniels O, Van Heyst A, Van Lier H, Festen C (2002) The influence of ductal left-to-right shunting during extracorporeal membrane oxygenation. J Pediatr Surg 37:1165-1168
14. Wallgren EI (1962) Pulmonary and renal circulation in children with patent ductus arteriosus. Pre- and post-operative studies of thirty-four cases. Acta Paediatr 51(Suppl 138): 1